Meet two leaders in immunotherapy and melanoma: Krista Rubin, MS, RN, FNP-BC, of the Center for Melanoma at Massachusetts General Hospital in Boston, and Anthony J. Olszanski, MD, RPh, Vice Chair of the Department of Hematology/Oncology and Director of the Early Drug Development Phase 1 Program at Fox Chase Cancer Center in Philadelphia.